SMAD4 loss is associated with cetuximab resistance and induction of MAPK/JNK activation in head and neck cancer cells

Hiroyuki Ozawa, Ruchira S. Ranaweera, Evgeny Izumchenko, Eugene Makarev, Alex Zhavoronkov, Elana J. Fertig, Jason D. Howard, Ana Markovic, Atul Bedi, Rajani Ravi, Jimena Perez, Quynh Thu Le, Christina S. Kong, Richard C. Jordan, Hao Wang, Hyunseok Kang, Harry Quon, David Sidransky, Christine H. Chung

Research output: Contribution to journalArticlepeer-review

29 Citations (Scopus)

Fingerprint Dive into the research topics of 'SMAD4 loss is associated with cetuximab resistance and induction of MAPK/JNK activation in head and neck cancer cells'. Together they form a unique fingerprint.

Medicine & Life Sciences